• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Diabetes in the News: PQA Speakers Focus on Prevention, Gaps in Care

Article

There is a role for pharmacists and pharmacy quality measures in addressing the public health challenge of diabetes, according to speakers at a recent virtual meeting this week.

Several speakers at the Pharmacy Quality Alliance (PQA) 2021 Online Annual Meeting discussed the public health challenge of diabetes and the role that pharmacies and pharmacy quality measures can play.

Diabetes prevention programs (DPP) can assist individuals in making lasting behavioral changes in order to halt a slide to type 2 diabetes (T2D), a report from Pharmacy Times noted. Panelists from Tabula Rasa HealthCare spoke about their DPP, which involves on-demand digital, telehealth, and a participant portal; the goal is to nudge participants to lose 5% to 7% of body weight through weekly and monthly sessions with a lifestyle coach.

Focusing on preventing costly diseases in the first place will help lower the overall cost of care, they note.

Read the full story on Pharmacy Times.

Also at PQA, a Walgreens executive discussed how the pharmacy chain is attempting to address social determinants of health on the South Side of Chicago with interventions aimed at addressing gaps in care in diabetes.

A diabetes outreach program uses predictive analytics and selects patients based on their adherence patterns, according to Michael Taitel, PhD, senior director of health analytics, research, and reporting at Walgreens.

According to the Pharmacy Times report, the program has addressed disparities in diabetes care, leading to significant improvements in adherence, statin use, and flu vaccinations among patients with diabetes.

In the 16 stores that implemented interventions, there was a 2.1% improvement in the percent of diabetes prescriptions being refilled within 2 weeks of their due date, compared to no improvement in stores that did not implement the program. Similarly, the test stores saw a 3.4% improvement in the percent of statin prescriptions refilled within 2 weeks of their due date, and a 25.0% improvement in the number of flu vaccinations administered at the pharmacy.

Read the full story on Pharmacy Times.

Related Videos
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Dr Chris Pagnani
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Screenshot of Mary Dunn, MSN, NP-C, OCN, RN, during a video interview
Seth Berkowitz, MD, MPH, associate professor of medicine, University of North Carolina at Chapel Hill
Inma Hernandez, PharmD, PhD, professor at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences
Binod Dhakal, MD
Screenshot of Joshua Meeks, MD, PhD, during a video interview
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.